Literature DB >> 33556480

Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains.

Abed Zahedi Bialvaei1, Mohammad Rahbar2, Ramin Hamidi-Farahani3, Ali Asgari3, Aylin Esmailkhani4, Yasaman Mardani Dashti5, Saeed Soleiman-Meigooni6.   

Abstract

Resistance-Nodulation-Division (RND) efflux pumps are responsible for multidrug resistance in Pseudomonas aeruginosa. The present study aimed to evaluate the overexpression of RND efflux pumps and its role in the antibiotic resistance of P. aeruginosa clinical isolates. A number of 122 isolates were obtained from three military hospitals in Tehran, Iran. In order to determine the antibiotic resistance, the isolates were identified and assessed by the disk diffusion and agar dilution methods. This study investigated the gene expression of four multi-drug efflux pump systems (MexAB-OprM, MexCD-OprJ, MexEF-OprN and MexXY (-OprA)) and its correlation with antibiotic resistance. The isolates indicated that the highest resistance rate was against ticarcillin (80%), followed by ciprofloxacin (74%) and meropenem (71%). Most of them expressed mexB (69%), mexC (28.7%), mexE (43.4%), and mexY (74.6%), suggesting that mexB and mexY were highly expressed in the studied strains. The overexpression of mexB and mexY was significantly more prevalent in the ICU wards (p = 0.033). Furthermore, there was a significant correlation between the expression of RND-type efflux pumps and the resistance to most anti-pseudomonal antibiotics.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Efflux pump inhibitor; Gene expression; MexAB-OprM; MexCD-OprJ; MexXY-OprA; Pseudomonas aeruginosa

Year:  2021        PMID: 33556480     DOI: 10.1016/j.micpath.2021.104789

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

1.  Characterization and genome analysis of Pseudomonas aeruginosa phage vB_PaeP_Lx18 and the antibacterial activity of its lysozyme.

Authors:  Yin Yin; Xinwei Wang; Zehua Mou; Huiying Ren; Can Zhang; Ling Zou; Huanqi Liu; Wenhua Liu; Zongzhu Liu
Journal:  Arch Virol       Date:  2022-06-18       Impact factor: 2.685

2.  Recognition of quinolone antibiotics by the multidrug efflux transporter MexB of Pseudomonas aeruginosa.

Authors:  Silvia Gervasoni; Giuliano Malloci; Andrea Bosin; Attilio V Vargiu; Helen I Zgurskaya; Paolo Ruggerone
Journal:  Phys Chem Chem Phys       Date:  2022-07-13       Impact factor: 3.945

Review 3.  Genetic Determinants of Antibiotic Resistance in Francisella.

Authors:  Stephen J Kassinger; Monique L van Hoek
Journal:  Front Microbiol       Date:  2021-05-12       Impact factor: 5.640

4.  Co-expression Mechanism Analysis of Different Tachyplesin I-Resistant Strains in Pseudomonas aeruginosa Based on Transcriptome Sequencing.

Authors:  Jun Hong; Xinyang Li; Mengyao Jiang; Ruofei Hong
Journal:  Front Microbiol       Date:  2022-04-07       Impact factor: 6.064

5.  Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model.

Authors:  Jessica R Tait; Hajira Bilal; Kate E Rogers; Yinzhi Lang; Tae-Hwan Kim; Jieqiang Zhou; Steven C Wallis; Jürgen B Bulitta; Carl M J Kirkpatrick; David L Paterson; Jeffrey Lipman; Phillip J Bergen; Jason A Roberts; Roger L Nation; Cornelia B Landersdorfer
Journal:  Antibiotics (Basel)       Date:  2022-01-13

Review 6.  Antimicrobial Peptides: From Design to Clinical Application.

Authors:  Chunye Zhang; Ming Yang
Journal:  Antibiotics (Basel)       Date:  2022-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.